Objective: To evaluate the post-op impact of local Methylen Blue injection on pain management and its safety. Study design: prospective, randomized, double-blinded, controlled study, performed in 100 patients (50 for each group), subjective pain levels were scored up to 2 weeks, based on a visual analogue scale.